Downregulation of polo-like kinase 4 in hepatocellular carcinoma associates with poor prognosis

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Liu, Lili ^a   Zhang, Chris Zhiyi ^a   Cai, Muyan ^a   Fu, Jia ^a   Chen, George Gong ^b   Yun, Jingping ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

POLO LIKE KINASE; POLO LIKE KINASE 4; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DOWN REGULATION; ENZYME REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECURRENCE FREE SURVIVAL; TISSUE MICROARRAY; TUMOR DIFFERENTIATION; TUMOR VOLUME;

BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; HUMANS; LIVER NEOPLASMS; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84864069838     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041293     Document Type: Article

References (33)

1. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, et al. (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35: 421-430.
2. He J, Gu D, Wu X, Reynolds K, Duan X, et al. (2005) Major causes of death among men and women in China. N Engl J Med 353: 1124-1134.
3. Seeff LB, Hoofnagle JH, (2006) Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity. Oncogene 25: 3771-3777.
4. Feo F, De Miglio MR, Simile MM, Muroni MR, Calvisi DF, et al. (2006) Hepatocellular carcinoma as a complex polygenic disease. Interpretive analysis of recent developments on genetic predisposition. Biochim Biophys Acta 1765: 126-147.
5. Kwon OS, Jung YK, Kim YS, Kim SG, Kim YS, et al. (2010) Effect of alcohol on the development of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis: a cross-sectional case-control study. Korean J Hepatol 16: 308-314.
6. Chen Ban K, Singh H, Krishnan R, Fong Seow H, (2004) Comparison of the expression of beta-catenin in hepatocellular carcinoma in areas with high and low levels of exposure to aflatoxin B1. J Surg Oncol 86: 157-163.
7. Nishida N, Goel A, (2011) Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review. Curr Genomics 12: 130-137.
8. Barr FA, Sillje HH, Nigg EA, (2004) Polo-like kinases and the orchestration of cell division. Nat Rev Mol Cell Biol 5: 429-440.
9. Sunkel CE, Glover DM, (1988) polo, a mitotic mutant of Drosophila displaying abnormal spindle poles. J Cell Sci 89 (Pt 1): 25-38.
10. Glover DM, Hagan IM, Tavares AA, (1998) Polo-like kinases: a team that plays throughout mitosis. Genes Dev 12: 3777-3787.
11. Sanchez Y, Bachant J, Wang H, Hu F, Liu D, et al. (1999) Control of the DNA damage checkpoint by chk1 and rad53 protein kinases through distinct mechanisms. Science 286: 1166-1171.
12. Liu L, Zhang M, Zou P, (2010) Polo-like kinase 1 is essential to DNA damage recovery. Leuk Lymphoma 51: 1079-1089.
13. Takai N, Hamanaka R, Yoshimatsu J, Miyakawa I, (2005) Polo-like kinases (Plks) and cancer. Oncogene 24: 287-291.
14. Winkles JA, Alberts GF, (2005) Differential regulation of polo-like kinase 1, 2, 3, and 4 gene expression in mammalian cells and tissues. Oncogene 24: 260-266.
15. Rosario CO, Ko MA, Haffani YZ, Gladdy RA, Paderova J, et al. (2010) Plk4 is required for cytokinesis and maintenance of chromosomal stability. Proc Natl Acad Sci U S A 107: 6888-6893.
16. Habedanck R, Stierhof YD, Wilkinson CJ, Nigg EA, (2005) The Polo kinase Plk4 functions in centriole duplication. Nat Cell Biol 7: 1140-1146.
17. Eckerdt F, Yamamoto TM, Lewellyn AL, Maller JL, (2011) Identification of a polo-like kinase 4-dependent pathway for de novo centriole formation. Curr Biol 21: 428-432.
18. Fode C, Binkert C, Dennis JW, (1996) Constitutive expression of murine Sak-a suppresses cell growth and induces multinucleation. Mol Cell Biol 16: 4665-4672.
19. Hudson JW, Kozarova A, Cheung P, Macmillan JC, Swallow CJ, et al. (2001) Late mitotic failure in mice lacking Sak, a polo-like kinase. Curr Biol 11: 441-446.
20. Ko MA, Rosario CO, Hudson JW, Kulkarni S, Pollett A, et al. (2005) Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis. Nat Genet 37: 883-888.
21. Pellegrino R, Calvisi DF, Ladu S, Ehemann V, Staniscia T, et al. (2010) Oncogenic and tumor suppressive roles of polo-like kinases in human hepatocellular carcinoma. Hepatology 51: 857-868.
22. Macmillan JC, Hudson JW, Bull S, Dennis JW, Swallow CJ, (2001) Comparative expression of the mitotic regulators SAK and PLK in colorectal cancer. Ann Surg Oncol 8: 729-740.
23. Pellegrino R, Calvisi DF, Ladu S, Ehemann V, Staniscia T, et al. (2010) Oncogenic and tumor suppressive roles of polo-like kinases in human hepatocellular carcinoma. Hepatology 51: 857-868.
24. Ward A, Morettin A, Shum D, Hudson JW, (2011) Aberrant methylation of Polo-like kinase CpG islands in Plk4 heterozygous mice. BMC Cancer 11: 71.
25. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, et al. (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4: 844-847.
26. Schmittgen TD, Livak KJ, (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108.
27. Yamada H, Sano Y, (1985) The biotinylation of the rabbit serotonin antibody and its application to immunohistochemical studies using the two-step ABC method. Histochemistry 83: 285-289.
28. Zimling ZG, Sorensen JB, Gerds TA, Bech C, Andersen CB, et al. (2012) Low ERCC1 expression in malignant pleural mesotheliomas treated with cisplatin and vinorelbine predicts prolonged progression-free survival. J Thorac Oncol 7: 249-256.
29. Fode C, Motro B, Yousefi S, Heffernan M, Dennis JW, (1994) Sak, a murine protein-serine/threonine kinase that is related to the Drosophila polo kinase and involved in cell proliferation. Proc Natl Acad Sci U S A 91: 6388-6392.
30. Tanenbaum ME, Medema RH, (2007) Cell fate in the Hand of Plk4. Nat Cell Biol 9: 1127-1129.
31. Zhou L, Rui JA, Wang SB, Chen SG, Qu Q, (2011) Prognostic factors of solitary large hepatocellular carcinoma: the importance of differentiation grade. Eur J Surg Oncol 37: 521-525.
32. Jonas S, Bechstein WO, Steinmuller T, Herrmann M, Radke C, et al. (2001) Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 33: 1080-1086.
33. Marwoto W, Miskad UA, Siregar NC, Gani RA, Boedihusodo U, et al. (2000) Immunohistochemical study of P53, PCNA and AFP in hepatocellular carcinoma, a comparison between Indonesian and Japanese cases. Kobe J Med Sci 46: 217-229.